Approval · Notice of Compliance 23324 · 2020
METONIA: Notice of Compliance 23324
Issued March 11, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23324
- Date
- March 11, 2020
- Company
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Revisions to labelling and the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METONIA | Not yet assigned | — |
Medicinal ingredients
- METOCLOPRAMIDE HCL 5 MG per TAB
- METOCLOPRAMIDE HCL 10 MG per TAB
- METOCLOPRAMIDE HCL 1 MG per ML